Millions of people worldwide suffer from gum disease, yet we still don't fully understand how healthy gums turn into damaged, ...
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer ...
A team of researchers has conducted the largest and most comprehensive genome-wide association study (GWAS) to date of ...
Researchers highlight how exercise and dietary strategies may complement immunotherapy by improving immune function, tumour ...
News Medical on MSN
Newly discovered survival pathway explains stubborn EGFR-driven lung cancers
Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene ...
Researchers say they have finally discovered the pathway by which obesity causes runaway inflammation that can lead to a host ...
The tumor microenvironment (TME) is a metabolically dynamic niche where cancer cells and immune cells interact to influence tumor progression and immune ...
Morning Overview on MSN
New study flags powerful drug target that could transform glaucoma treatment
Glaucoma has long been treated as a plumbing problem of the eye, managed mainly by lowering pressure rather than protecting ...
The U.S. Food and Drug Administration (FDA) has accepted a new drug application for gedatolisib for the treatment of patients ...
A team of researchers led by scientists from the Icahn School of Medicine at Mount Sinai, SUNY Downstate Health Sciences University, and the ...
Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results